Tositumomab and iodine I 131 tositumomab | |
---|---|
Trade Name | Bexxar |
Orphan Indication | Non-Hodgkin's B-cell lymphoma |
USA Market Approval | USA |
USA Designation Date | 1994-05-16 00:00:00 |
Sponsor | GlaxoSmithKline LLC;Corporation Service Company, 2711 Centerville Road, Suite 400;Wilmington, Delaware, 19808 |